Prospective study of human betaherpesviruses after renal transplantation. Association of human herpesvirus 7 and cytomegalovirus co- infection with cytomegalovirus disease and increased rejection

Transplantation

Volumn 69, Issue 11, 2000, Pages 2400-2404

  Kidd, I Michael ^a   Clark, Duncan A ^a   Sabin, Caroline A ^a   Andrew, Dawn ^a   Hassan Walker, Aycan F ^a   Sweny, Paul ^a   Griffiths, Paul D ^a   Emery, Vincent C ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; HUMAN TISSUE; INFECTION RATE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VIRUS DETECTION; VIRUS LOAD;

EID: 0034659776     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200006150-00032     Document Type: Article

References (38)

1. Salahuddin SZ, Ablashi DV, Markham PD, et al. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986; 234: 596.
2. Frenkel N, Schirmer EC, Wyatt LS, et al. Isolation of a new herpesvirus from CD4+ T-cells. Proc Natl Acad Sci USA 1990; 87: 748.
3. Lusso P, Malnati M, De Maria A, et al. Productive infection of CD4+ and CD8+ mature human T cell populations and clones by human herpesvirus 6. Transcriptional down-regulation of CD3. J Immunol 1991; 147: 685.
4. Lusso P, Secchiero P, Crowley RW, et al. CD4 is a critical component of the receptor for human herpesvirus 7: interference with human immunodeficiency virus. Proc Natl Acad Sci USA 1994; 91: 3872.
5. Yamanishi K, Okuna T, Shiraki K, et al. Identification of human herpesvirus 6 as a causal agent for exanthem subitum. Lancet 1988; i: 1065.
6. Hall CB, Long CE, Schnabel KC, et al. Human herpesvirus-6 infection in children: a prospective study of complications and reactivation. J Clin Microbiol 1994; 331: 432.
7. Clark DA, Kidd IM, Collingham KE, et al. Diagnosis of primary human herpesvirus 6 and 7 infections in febrile infants by polymerase chain reaction. Arch Dis Child 1997; 77: 42.
8. Griffiths PD. Cytomegalovirus. In: Zuckerman AJ, Banatvala JE, Pattison JR, eds. Principles and practice of clinical virology, 3rd Ed. Chichester, United Kingdom: Wiley, 1996: 69.
9. Jacobs U, Ferber J, Klehr HU. Severe allograft dysfunction after OKT3-induced human herpes virus-6 reactivation. Transplant Proc 1994; 26: 3121.
10. Yoshikawa T, Suga S, Asano Y, et al. Human herpesvirus-6 infection in bone marrow transplantation. Blood 1991; 78: 1381.
11. Drobyski WR, Dunne WM, Burd EM, et al. Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: evidence of a marrow-suppressive role for HHV-6 in vivo. J Infect Dis 1993; 167: 735.
12. Carrigan DR, Knox KK. Human herpesvirus 6 (HHV-6) isolation from bone marrow: HHV-6-associated bone marrow suppression in bone marrow transplant patients. Blood 1994; 84: 3307.
13. Ward KN, Gray JJ, Efstathiou S. Primary human herpesvirus 6 infection in a patient following liver transplantation from a seropositive donor. J Med Virol 1989; 28: 67.
14. Drobyski WR, Knox KK, Majewski D, Carrigan DR. Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. J Clin Microbiol 1994; 330: 1356.
15. Cone RW, Hackman RC, Huang ML, et al. Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation. J Clin Microbiol 1993; 329: 156.
16. Carrigan DR, Drobyski WR, Russler SK, Tapper MA, Knox KK, Ash RC. Interstitial pneumonitis associated with human herpesvirus-6 infection after marrow transplantation. Lancet 1991; 338: 147.
17. Wilborn F, Brinkmann V, Schmidt CA, Neipel F, Gelderblom H, Siegert W. Herpesvirus type 6 in patients undergoing bone marrow transplantation: serologic features and detection by polymerase chain reaction. Blood 1994; 83: 3052.
18. Yoshikawa T, Suga S, Asano Y, et al. A prospective study of human herpesvirus-6 infection in renal transplantation. Transplantation 1992; 54: 879.
19. Appleton AL, Sviland L, Peiris JSM, et al. Human herpes virus-6 infection in marrow graft recipients: role in pathogenesis of graft-versus-host disease. Bone Marrow Transplant 1995; 16: 777.
20. Herbein G, Strasswimmer J, Altieri M, Woehl-Jaegle ML, Wolf P, Obert G. Longitudinal study of human herpesvirus-6 infection in organ transplant recipients. Clin Infect Dis 1996; 22: 171.
21. Osman HK, Peiris JS, Taylor CE, Warwicker P, Jarrett RF, Madeley CR. "Cytomegalovirus disease" in renal allograft recipients: is human herpesvirus 7 a co-factor for disease progression? J Med Virol 1996; 48: 295.
22. DesJardin JA, Gibbons L, Cho E, et al. Human herpesvirus 6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infection. J Infect Dis 1998; 178: 1783.
23. Ratnamohan VM, Chapman J, Howse H, et al. Cytomegalovirus and human herpesvirus 6 both cause viral disease after renal transplantation. Transplantation 1998; 66: 877.
24. Kidd IM, Clark DA, Ait-Khaled M, Griffiths PD, Emery VC. Measurement of human herpesvirus 7 load in peripheral blood and saliva of healthy subjects by quantitative polymerase chain reaction. J Infect Dis 1996; 174: 396.
25. Griffiths PD, Ait-Khaled M, Bearcroft CP, et al. Human herpesviruses 6 and 7 as potential pathogens after liver transplant: prospective comparison with the effect of cytomegalovirus. J Medical Virol 1999; 59: 496.
26. Kidd IM, Clark DA, Bremner JAG, Pillay D, Griffiths PD, Emery VC. A multiplex PCR assay for the simultaneous detection of human herpesvirus 6 and human herpesvirus 7, with typing of HHV-6 by enzyme cleavage of PCR products. J Virol Methods 1998; 70: 29.
27. Ljungman P, Griffiths PD. Definitions of cytomegalovirus infection and disease. In: Michelson S, Plotkin SA, eds. Multidisciplinary approach to understanding cytomegalovirus disease. Amsterdam: Excerpta Medica, 1993: 233.
28. Kidd IM, Fox JC, Pillay D, Charman H, Griffiths PD, Emery VC. Provision of prognostic information in immunocompromised patients by routine application of the polymerase chain reaction for cytomegalovirus. Transplantation 1993; 56: 867.
29. Fox JC, Griffiths PD, Emery VC. Quantification of human cytomegalovirus DNA using the polymerase chain reaction. J Gen Virol 1992; 73: 2405.
30. Clark DA, Ait-Khaled M, Wheeler AC, et al. Quantification of human herpesvirus 6 in immunocompetent persons and postmortem tissues from AIDS patients by PCR. J Gen Virol 1996; 77: 2271.
31. Yoshikawa T, Nakashima T, Asano Y, et al. Endonuclease analyses of DNA of human herpesvirus-6 isolated from blood before and after bone marrow transplantation. J Med Virol 1992; 37: 228.
32. Torelli G, Barozzi P, Marasca R, et al. Targeted integration of human herpesvirus 6 in the p-arm of chromosome 17 of human peripheral blood mononuclear cells in vivo. J Med Virol 1995; 46: 178.
33. Meyers JD, Ljungman P, Fisher LD. Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: importance of cytomegalovirus viremia. J Infect Dis 1990; 162: 373.
34. Ljungman P, Lore K, Aschan J, et al. Use of a semi-quantitative PCR for cytomegalovirus DNA as a basis for pre-emptive antiviral therapy in allogeneic bone marrow transplant patients. Bone Marrow Transplant 1996; 17: 583.
35. Wang FZ, Dahl H, Linde A, Brytting M, Ehrnst A, Ljungman P. Lymphotropic herpesviruses in allogeneic bone marrow transplantation. Blood 1996; 88: 3615.
36. Lao WC, Lee D, Burroughs AK, et al. Use of the polymerase chain reaction to provide prognostic information on human cytomegalovirus disease after liver transplantation. J Med Virol 1997; 51: 152.
37. Kempf W, Adams V, Mirandola P, et al. Persistence of human herpesvirus 7 in normal tissues detected by expression of a structural antigen. J Infect Dis 1998; 178: 841.
38. Lowance D, Neumayer HH, Legendre CM, et al. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. N Engl J Med 1999; 340: 1462.